Omega Therapeutics (OMGA) : 3-year performance

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform.

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 93
• Founded by Noubar B. Afeyan and David Berry on July 13, 2016
• Headquartered in Cambridge, Massachusetts
• https://omegatherapeutics.com

IPO: July 30, 2021 on the Nasdaq Global Select Market

Ticker: OMGA

3 months later (Feb 11, 25)

IPOs this week : Aug 23 - 27, 21 (wk 34)

IPO quiet period expirations

• Traeger (NYSE:COOK), 
• Duolingo (NASDAQ:DUOL), 
• Robinhood Markets (HOOD), 
• Icosavax (NASDAQ:ICVX), 
• MeridianLink (NYSE:MLNK), 
• Rallybio (NASDAQ:RLYB), 
• Riskified (NYSE:RSKD), 
• Snap One (NASDAQ:SNPO), 
• Dole (NYSE:DOLE), 
• Omega Therapeutics (NASDAQ:OMGA), 
• RxSight (NASDAQ:RXST) and 
• Tenaya Therapeutics (NASDAQ:TNYA).